Stock Price Quote

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE2028.552.9 (+0.14 %)
PREV CLOSE ( ) 2025.65
OPEN PRICE ( ) 1936.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6696
TODAY'S LOW / HIGH ( )1936.95 2087.95
52 WK LOW / HIGH ( )247.3 2350
NSE2026.001.55 (+0.08 %)
PREV CLOSE( ) 2024.45
OPEN PRICE ( ) 2018.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 56120
TODAY'S LOW / HIGH( ) 2000.00 2090.00
52 WK LOW / HIGH ( )245.75 2350
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 07-01 1984
Management Info
Davuluri Rama Mohan Rao - Chairman Davuluri Rama Mohan Rao - Managing Director
Registered Office

Address Sanali Info Park, 'a' Block,Ground Floor,8-2-120/113,Road No.2, Banjara Hills,
Hyderabad,
Telangana-500034

Phone 040-30211600

Email ir@neulandlabs.com

Website www.neulandlabs.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

07Jan Update on board meeting
The Board Meeting to be held on 03/02/2021 has been revised to 02/02/202..
07Jan Board Meeting Intimation for Consider
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board..
04Aug Neuland Laboratories informs about pre
Neuland Laboratories has informed that the Company enclosed a copy of th..
08May Reliance Industries, Neuland Laborator
Vista Equity Partners (Vista) will invest Rs 11,367 crore into Reliance..
08May Neuland Laboratories receives EIR from
Neuland Laboratories has received Establishment Inspection Report (EIR)..

Financials

in Millions
QTR Dec 20 ANNUAL 20
Net Profit266.73158.81
Gross Profit 318.59 524.97
Operating Profit 467.051053.44
Net Sales 2453.927627.11

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  8268.85 (1.40%)
M.Cap ( in Cr)19043.68
Abbott India (BSE)
peergroup  14396.65 (0.34%)
M.Cap ( in Cr)30591.88
Orchid Pharma (BSE)
peergroup  885.15 (5.00%)
M.Cap ( in Cr)3612.86
Alembic Pharma (BSE)
peergroup  919.15 (2.38%)
M.Cap ( in Cr)18067.10
Natural Capsules (BSE)
peergroup  117.40 (19.98%)
M.Cap ( in Cr)73.17

Shareholding Pattern

NON-INSTITUTION 40.73%
PROMOTERS 36.25%
MUTUAL FUNDS/UTI 2.68%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Neuland Laboratories Ltd.

Neuland Laboratories Ltd. was incorporated in the year 1984. Its today's share price is 2028.55. Its current market capitalisation stands at Rs 2602.61 Cr. In the latest quarter, company has reported Gross Sales of Rs. 7627.11 Cr and Total Income of Rs.7665.97 Cr. The company's management includes Sarada Bhamidipati, Christopher M Cimarusti, Homi Rustam Khusrokhan, Nirmala Murthy, Bharati Rao, William Gordon Mitchell, Parampally Vasudeva Maiya, Humayun Dhanrajgir, Davuluri Saharsh Rao, Davuluri Sucheth Rao, Davuluri Rama Mohan Rao, Davuluri Rama Mohan Rao.

It is listed on the BSE with a BSE Code of 524558 , NSE with an NSE Symbol of NEULANDLAB and ISIN of INE794A01010. It's Registered office is at Sanali Info Park, 'a' Block,Ground Floor,8-2-120/113,Road No.2, Banjara HillsHyderabad-500034, Telangana. Their Registrars are ACC Ltd. It's auditors are KS Aiyar & Co, MSKA & Associates, Walker Chandik & Co LLP, Walker Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)